The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa
about
Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review.Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosisEvolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapySpontaneous emergence of multiple drug resistance in tuberculosis before and during therapyProgrammatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South AfricaWhole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from PakistanGenome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug ResistanceThe Host Response to a Clinical MDR Mycobacterial Strain Cultured in a Detergent-Free Environment: A Global Transcriptomics ApproachFitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymeraseDiarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype.Detecting novel genetic variants associated with isoniazid-resistant Mycobacterium tuberculosis.Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probeImportance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosisPopulation structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa.Evolution and transmission patterns of extensively drug-resistant tuberculosis in China.Polymorphisms in isoniazid and prothionamide resistance genes of the Mycobacterium tuberculosis complex.Genomic epidemiology of multidrug-resistant Mycobacterium tuberculosis during transcontinental spreadFluorogenic probes with substitutions at the 2 and 7 positions of cephalosporin are highly BlaC-specific for rapid Mycobacterium tuberculosis detection.Microevolution of extensively drug-resistant tuberculosis in Russia.Mycobacterium tuberculosis--heterogeneity revealed through whole genome sequencing.The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa.Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients.Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission.Tuberculosis caused by RDRio Mycobacterium tuberculosis is not associated with differential clinical featuresMutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosisMycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai.Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant M. tuberculosis strain from South AfricaIndoleamides are active against drug-resistant Mycobacterium tuberculosisThe impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis.Genomic insights into tuberculosis.Development of a One-Step Multiplex PCR Assay for Differential Detection of Major Mycobacterium Species.The essential role of SepF in mycobacterial division.Quantitative detection of cells expressing BlaC using droplet-based microfluidics for use in the diagnosis of tuberculosisWhole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand.Consequences of whiB7 (Rv3197A) mutations in Beijing genotype isolates of the Mycobacterium tuberculosis complex.Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa.
P2860
Q26752616-8290195E-CD3C-48AA-97E7-21519AAD1772Q26824812-9AD58264-6A0B-4397-A577-AE511F90AD28Q27016579-9DD689ED-B96A-4368-A6E7-6B072E176EA5Q28477566-83663CC5-24CC-4FD8-98BB-A93F1FA6E4D1Q28535594-CAB7DAC6-7EDB-4F5D-B402-0F38962D8412Q28543682-7F1B1AA2-CA86-4526-8AC9-969E5BF1B663Q28545741-E9265902-274B-4CD4-94F4-515664775310Q28551251-C730C0A8-115E-4653-B866-6959C8A4407BQ30153449-71206D9B-E7FA-4A72-B53F-08BC1B157D6BQ30432374-19D06652-F13F-42F3-827A-9DFAC9EE2B9EQ30555347-A6337845-FBF2-44A2-8833-647C4614D270Q33905492-248FBB3F-3D44-4D6D-A2E5-BCFEB12A49BFQ34060501-EFC19DC4-109B-4875-9743-0030BC27818AQ34092117-75C8F33C-1AF5-4770-A6C6-F1D210D75D96Q34101580-9177AEF6-1BF6-416C-A131-BE6D31B63C8DQ35105967-BFC15A72-489D-4F47-8DF8-705798C6BA7AQ35191465-73CEF461-B230-40B6-8E93-E3CDF6F89BC6Q35812947-08112CCF-D3A0-4107-90D2-0200E1ABFBB7Q35842780-8D8C56F8-D09F-4EE1-A774-C833177A4AF7Q35864738-C61EAF51-CE58-454A-8584-65F2CDA646EAQ35881532-A37F2814-47A0-4AD8-A5B7-36DB9599DEB9Q36094198-4D27180C-84AF-44CB-B7E6-8BECE60AD53EQ36173979-3E9DCAB0-9F7D-4752-B787-937C0FE5772FQ36368678-BD77A42A-64C8-494C-AFF4-0CC2F860A4A0Q36558393-886A95DD-DEE5-4F51-B135-37E12069FD1EQ37059870-C8CC149D-A5FB-4607-AD8E-B9FE488F8BF1Q37120065-B6E24246-7F4D-4C28-94A0-526D68B045B1Q37184072-AD6B92A4-552F-4FDB-BDD2-CF91EF970174Q37249837-64CAE3D0-16B1-4BF1-8285-8F573C35A761Q37264289-CA544CA2-2C24-4D93-B12D-3711A1965C7CQ37541307-F0238606-E318-4630-A490-D07BA5826270Q37683485-A97059C4-69AB-48F3-B112-7CD3D6C564B6Q38144839-BDF497B3-330F-457D-9A5B-66E3CD7D6280Q38198853-672D837D-2508-4FEF-8EBC-ED9C2258848FQ40154522-D6ADAA44-F76E-4CF9-8BC2-C768D6D89320Q40974615-AA664EAE-8017-4417-9DF5-7D2DCD90EF22Q42041395-679EBCFE-AEA5-4EEE-9DC3-BD6FC085665DQ42146421-3CC619B6-7AEB-4C18-B017-7C6D993ACAC5Q43110599-D3A05BA6-FE55-4A9C-9D4D-676440938156Q46379063-B4645E8B-8E93-4053-817D-27EFA356E06E
P2860
The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The non-clonality of drug resi ...... e Western Cape of South Africa
@ast
The non-clonality of drug resi ...... e Western Cape of South Africa
@en
type
label
The non-clonality of drug resi ...... e Western Cape of South Africa
@ast
The non-clonality of drug resi ...... e Western Cape of South Africa
@en
prefLabel
The non-clonality of drug resi ...... e Western Cape of South Africa
@ast
The non-clonality of drug resi ...... e Western Cape of South Africa
@en
P2093
P2860
P50
P921
P356
P1433
P1476
The non-clonality of drug resi ...... e Western Cape of South Africa
@en
P2093
James C Sacchettini
Paul D Van Helden
Thomas C Victor
Thomas R Ioerger
Xiaohua Chen
Yicheng Feng
P2860
P2888
P356
10.1186/1471-2164-11-670
P407
P577
2010-11-26T00:00:00Z
P5875
P6179
1024232741